We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Urinary Test Diagnoses Cancer and Infertility-Causing Parasite

By LabMedica International staff writers
Posted on 03 Jun 2014
A fast, noninvasive way to test for a cancer-causing parasite that kills hundreds of thousands of people every year has been discovered. More...


About 243 million people are infected with schistosomiasis, which kills about 200,000 people every year and following infection, women often contract female genital schistosomiasis, which affects the cervix and uterus resulting in bleeding and pain during sex and infertility.

Scientists at the University of Porto (Portugal) collaborating with their colleagues in Angola, conducted a cross-sectional study of female residents of a region in Bengo province (Angola), endemic for schistosomiasis haematobia. Ninety-three women and girls, aged from two to 94 years were interviewed on present and previous urinary, urogenital and gynecological symptoms and complaints. Urine was collected from the participants for egg-based parasitological assessment of schistosomal infection, and biochemical analysis.

The entire micturition volume was filtered through a polycarbonate membrane (Whatman plc; Springfield Mill, UK) and subsequently the membrane was stained with Trypan blue. Schistosome ova retained on the membrane were identified with the aid of a light microscope. Liquid chromatography diode array detection electron spray ionization mass spectrometry (LC/UV-DAD/ESI-MSn) was performed on a Finnigan Surveyor Plus High-Performance Liquid Chromatography (HPLC) instrument (ThermoFinnigan; San Jose, CA, USA) equipped with a diode-array detector and a mass detector.

The investigators discovered catechols in the urine of women who tested positively for parasite eggs, but not in the urine of uninfected women. The team also found an association between catechols and infertility. In studying the mechanisms involved, the team found that the catechols downregulate estrogen receptors and trigger DNA mutations. Either or both of these actions could be responsible for the bladder cancer and infertility common to schistosomiasis patients.

Monica Catarina Botelho, PhD, the senior author of the study said, “Estrogen metabolism/degradation is a normal body process as estrogens are degraded into catechols and these into quinones. But if there are too many quinones, due to an excessive estrogen production or altered metabolism, this can cause DNA damage, because they tend to bind to DNA disturbing it. Now we detect these molecules not only in the serum, but also in the urine of patients infected with Schistosoma, while uninfected patients do not have them. They have been linked before to cancer as in thyroid, breast and prostate neoplasms, and autoimmunity. Now we see them in infertility associated with schistosomiasis infection.” The study was published on May 21, 2014, in the journal Public Library of Science ONE.

Related Links:

University of Porto
Whatman plc 
ThermoFinnigan



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.